Birdshot Chorioretinopathy: Treatment Stabilizes Vision
Visual acuity can remain stable in patients with birdshot chorioretinopathy (BSCR) for 10 years or more, a new study shows. Best corrected visual acuity (BCVA) remained stable in patients who received short-term corticosteroid treatment and those who received longer-term treatment with corticosteroids plus an immunosuppressive agent, according to an article published online December 12 in JAMA Ophthalmology. These findings suggest that "with modern treatment approaches, we can preserve visual acuity and visual field in patients with BSCR and even improve the visual field," said Douglas A. Jabs, MD, MBA, Professor and Chair of Ophthalmology at the Icahn School of Medicine at Mount Sinai, who was not involved in the study.
-Dr. Douglas A. Jabs, Professor, Chair, Ophthalmology, Icahn School of Medicine at Mount Sinai
Learn more
Mount Sinai Launches the Marilyn Monroe Mental Health for the Arts Program
Apr 30, 2026 View All Press Releases
A Promising Study Suggests a Blood Test Could Spot Alzheimer’s Early in Progression
Apr 21, 2026 View All Press Releases
New Research Reveals Autism Risk Genes Are Shared Across Ancestries
Mar 30, 2026 View All Press Releases
Icahn School of Medicine at Mount Sinai Remains Among Top Institutions for NIH Funding
Mar 05, 2026 View All Press Releases